PDSBVSPRME• 12 Months (Normalized)
PDSB vs PRME (PDS Biotechnology Corporation vs Prime Medicine Inc.)
Showing Closing Date Range from Sep, 16, 2025 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
PDSB Performance $0.99
-17.42%
PDS Biotechnology Corporation
Normalized Baseline0.00%
PRME Performance $3
-35.76%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin PDSB LEADS
+18.34%
PDSB outperforming by 18.34%
PDSBPRME
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
PDSB PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | PDSB Price | PDSB Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.99 | -17.42% | $3.00 | -35.76% | +18.34% |
| Sep 15, 2026 | $0.59 | -51.25% | $3.14 | -32.76% | -18.49% |
| Sep 14, 2026 | $0.40 | -66.75% | $3.18 | -31.91% | -34.84% |
| Sep 11, 2026 | $0.30 | -75.42% | $3.13 | -32.98% | -42.44% |
| Sep 10, 2026 | $0.32 | -73.75% | $3.35 | -28.27% | -45.48% |
| Sep 09, 2026 | $0.29 | -75.58% | $3.47 | -25.70% | -49.88% |
| Sep 08, 2026 | $0.30 | -75.00% | $3.56 | -23.77% | -51.23% |
| Sep 04, 2026 | $0.22 | -81.67% | $3.70 | -20.77% | -60.90% |
| Sep 03, 2026 | $0.22 | -81.67% | $3.71 | -20.56% | -61.11% |
| Sep 02, 2026 | $0.21 | -82.33% | $3.67 | -21.41% | -60.92% |
| Sep 01, 2026 | $0.20 | -83.00% | $3.57 | -23.55% | -59.45% |
| Aug 31, 2026 | $0.21 | -82.17% | $3.59 | -23.13% | -59.04% |
| Aug 28, 2026 | $0.21 | -82.42% | $3.61 | -22.70% | -59.72% |
| Aug 27, 2026 | $0.22 | -81.83% | $3.64 | -22.06% | -59.77% |
| Aug 26, 2026 | $0.22 | -81.42% | $3.58 | -23.34% | -58.08% |
Page 1 of 17